SCHEMBL20577484

SCHEMBL20577484

CCc1cccc(Oc2ncc(N3CCC(=O)NC3=O)cn2)c1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 10/20 0.45
DDB1 Q16531 9/20 0.45
ALOX5 P09917 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
GRM2 Q14416 1/20 0.39
SOD1 P00441 1/20 0.38
AURKB Q96GD4 1/20 0.37
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
HSD17B10 Q99714 1/20 0.37
ROCK2 O75116 1/20 0.37
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30483680 1.00 CRBN (0.45) CRBNDDB1ALOX5SMN1; SMN2KDM4E
SCHEMBL26449433 0.89 KDM4E (0.37) CRBNDDB1ALOX5SMN1; SMN2KDM4E
SCHEMBL22534751 0.85 CRBN (0.46) CRBNDDB1ALOX5KDM4EALDH1A1
SCHEMBL22534759 0.85 CRBN (0.46) CRBNDDB1ALOX5SMN1; SMN2AURKB
SCHEMBL22534784 0.85 DDB1 (0.56) CRBNDDB1ALOX5SMN1; SMN2KDM4E
SCHEMBL22534808 0.83 CRBN (0.44) CRBNDDB1SMN1; SMN2KDM4EALDH1A1
SCHEMBL22534760 0.83 CRBN (0.46) CRBNDDB1ALOX5SMN1; SMN2ALDH1A1
SCHEMBL22534722 0.83 CRBN (0.46) CRBNDDB1ALOX5AURKBROCK2
SCHEMBL30483684 0.83 CRBN (0.46) CRBNDDB1ALOX5AURKBROCK2
SCHEMBL22534797 0.83 CRBN (0.46) CRBNDDB1ALOX5SOD1AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230138411-A1 PYRIMIDINE COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2023-05-04 US disclosed
US-20230138411-A1 PYRIMIDINE COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2023-05-04 US disclosed
US-20230138411-A1 PYRIMIDINE COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2023-05-04 US disclosed
EP-3630729-B1 PYRIMIDINE COMPOUND OTSUKA PHARMA CO LTD (JP) 2021-11-03 EP disclosed
EP-3630729-B1 PYRIMIDINE COMPOUND OTSUKA PHARMA CO LTD (JP) 2021-11-03 EP disclosed
US-20200399245-A1 PYRIMIDINE COMPOUND OTSUKA PHARMACEUTICAL CO, LTD. (JP) 2020-12-24 US disclosed
US-20200399245-A1 PYRIMIDINE COMPOUND OTSUKA PHARMACEUTICAL CO, LTD. (JP) 2020-12-24 US disclosed
US-10800758-B2 Pyrimidine compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2020-10-13 US disclosed
US-10800758-B2 Pyrimidine compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2020-10-13 US disclosed
EP-3630729-A1 PYRIMIDINE COMPOUND Otsuka Pharmaceutical Co., Ltd. (JP) 2020-04-08 EP disclosed
CN-110603248-A Pyrimidine compounds 大塚制药株式会社 2019-12-20 CN disclosed
WO-2018221667-A1 PYRIMIDINE COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2018-12-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230138411-A1 PYRIMIDINE COMPOUND UMPS, TPMT, TYMS CRBN 4450/4885DDB1 2854/4885ALOX5 1795/4885
US-20200399245-A1 PYRIMIDINE COMPOUND UMPS, TPMT, TYMS CRBN 4450/4885DDB1 2854/4885ALOX5 1795/4885
US-10800758-B2 Pyrimidine compound UMPS, TPMT, TYMS CRBN 4450/4885DDB1 2854/4885ALOX5 1795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.